Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series B generates $14mm for Elcelyx; company extends round

Executive Summary

Elcelyx Therapeutics Inc. (developing therapies for obesity and related conditions) has raised $6mm in the first close of its Series B financing to returning shareholder Morgenthaler Venture Partners and first-time backers Kleiner Perkins Caufield & Byers and Technology Partners.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • Nutraceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies